No insider purchase over the last 90 days. The latest, by ADAMS ROBERT G, was filed 14 Sept 2023.
+2 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 482 declarations
National Healthcare Corp counts 85 sales for EUR 28,889,007 (median EUR 112,196) and 7 purchases for EUR 746,529, which is 8% of open-market trades. The three largest sales are filed under the name National Health Corp: EUR 7,360,027 on August 5, 2016, then EUR 3,087,854 on December 20, 2024 and EUR 2,666,555 on December 31, 2024.
On the purchase side, Robert G. Adams, Director, bought EUR 124,880 and EUR 121,967 on September 6, 2023, and Ernest G. Burgess III, Director, EUR 124,475 on May 15, 2023. From August 9 to September 6, 2023, two filers bought for EUR 360,715 in total.
The record gathers 482 filings from 26 filers between February 1, 2016 and September 23, 2026, including 183 grants and 164 option exercises. Stephen Fowler Flatt, CEO, signs 51 (3 sales), Ernest G. Burgess III 48 (26 sales and one purchase), Robert Michael Ussery, President & COO, 46 and James Paul Abernathy, Director, 40. The annual volume rose from 25 in 2017 to 78 in 2025. Over the last twelve months: 91 filings, 13 sales, no purchase. The company is valued at USD 3,883,086,336.
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 1.52 bn USD | 120.0 m USD | 7.67 USD | 2.53 USD | 10-K |
| Dec 2024 | 1.31 bn USD | 101.9 m USD | 6.53 USD | 2.42 USD | 10-K |
| Dec 2023 | 1.14 bn USD | 66.8 m USD | 4.34 USD | 2.34 USD | 10-K |
| Dec 2022 | 1.09 bn USD | 22.4 m USD | 1.45 USD | 2.26 USD | 10-K/A |
| Dec 2021 | 1.07 bn USD | 138.6 m USD | 8.99 USD | 2.11 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.